Comparable Long-Term Survival After Curative Hepatectomy for Solitary Large (5–10 cm) versus Giant (≥10 cm) Hepatocellular Carcinoma: A Retrospective Study

Kunyuan Jiang,1,* Jingfei Li,2,* Dongli Zhang,1 Weiping Wang,1 Jun Chang1 1Department of General Surgery, Kunshan Second People’s Hospital, Suzhou, Jiangsu, People’s Republic of China; 2Department of Emergency Surgery, The First Affiliated Hospital of the University of Science and Technology of China, Hefei, Anhui, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jun Chang, Department of General Surgery, Kunshan Second People’s Hospital, No. 999 Qianjin Road, Kunshan, Suzhou, Jiangsu, 215300, People’s Republic of China, Tel +86-18662547598, Email [email protected]: This study aims to compare long-term oncological outcomes after curative hepatectomy in patients with solitary large versus giant HCC.Patients and Methods: This dual-center study included 281 patients with solitary HCC ≥ 5 cm undergoing R0 hepatectomy, stratified into large (5– 10 cm) and giant (≥ 10 cm) cohorts. 1:1 PSM matched potential confounding variables. Primary endpoint was recurrence-free survival (RFS), analyzed through Kaplan-Meier methods with Log rank testing.Results: At baseline, giant HCC (n=90) patients exhibited significantly higher rates of AFP ≥ 200 ng/mL, major hepatectomy, and intraoperative transfusion compared to large HCC (n=191) cohort. After PSM, 82 patients were allocated to each group, with all baseline characteristics well-balanced. The RFS analysis revealed comparable outcomes between large and giant HCC groups: pre-PSM median RFS, 29.6 vs 26.5 months (HR 0.864, 95% CI 0.615– 1.214, P=0.398); post-PSM median RFS, 21.1 vs 26.5 months (HR 1.128, 95% CI 0.756– 1.681, P=0.555). Median overall survival (OS) was not reached in either group.Conclusion: Patients with solitary giant HCC amenable to upfront curative hepatectomy achieved similar RFS compared to large HCC after surgery, tumor biological characteristics (AFP levels and MVI status) are the primary determinants of postoperative prognosis in HCC patients.Keywords: hepatectomy, hepatocellular carcinoma, tumor size, recurrence-free survival, propensity score analysis

Authors

Publication Details

Journal
Dove Medical Press (Taylor and Francis Group)
Published
2026-06-08
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparable Long-Term Survival After Curative Hepatectomy for Solitary Large (5–10 cm) versus Giant (≥10 cm) Hepatocellular Carcinoma: A Retrospective Study

Jingfei Li, Kunyuan Jiang, Jun Chang, Dongli Zhang et al.
Dove Medical Press (Taylor and Francis Group)
Hepatocellular Carcinoma Treatment and Prognosis
article

Comparable Long-Term Survival After Curative Hepatectomy for Solitary Large (5–10 cm) versus Giant (≥10 cm) Hepatocellular Carcinoma: A Retrospective Study

Jingfei Li, Kunyuan Jiang, Jun Chang, Dongli Zhang, Weiping Wang
article en

Abstract

Kunyuan Jiang,1,* Jingfei Li,2,* Dongli Zhang,1 Weiping Wang,1 Jun Chang1 1Department of General Surgery, Kunshan Second People’s Hospital, Suzhou, Jiangsu, People’s Republic of China; 2Department of Emergency Surgery, The First Affiliated Hospital of the University of Science and Technology of China, Hefei, Anhui, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jun Chang, Department of General Surgery, Kunshan Second People’s Hospital, No. 999 Qianjin Road, Kunshan, Suzhou, Jiangsu, 215300, People’s Republic of China, Tel +86-18662547598, Email [email protected]: This study aims to compare long-term oncological outcomes after curative hepatectomy in patients with solitary large versus giant HCC.Patients and Methods: This dual-center study included 281 patients with solitary HCC ≥ 5 cm undergoing R0 hepatectomy, stratified into large (5– 10 cm) and giant (≥ 10 cm) cohorts. 1:1 PSM matched potential confounding variables. Primary endpoint was recurrence-free survival (RFS), analyzed through Kaplan-Meier methods with Log rank testing.Results: At baseline, giant HCC (n=90) patients exhibited significantly higher rates of AFP ≥ 200 ng/mL, major hepatectomy, and intraoperative transfusion compared to large HCC (n=191) cohort. After PSM, 82 patients were allocated to each group, with all baseline characteristics well-balanced. The RFS analysis revealed comparable outcomes between large and giant HCC groups: pre-PSM median RFS, 29.6 vs 26.5 months (HR 0.864, 95% CI 0.615– 1.214, P=0.398); post-PSM median RFS, 21.1 vs 26.5 months (HR 1.128, 95% CI 0.756– 1.681, P=0.555). Median overall survival (OS) was not reached in either group.Conclusion: Patients with solitary giant HCC amenable to upfront curative hepatectomy achieved similar RFS compared to large HCC after surgery, tumor biological characteristics (AFP levels and MVI status) are the primary determinants of postoperative prognosis in HCC patients.Keywords: hepatectomy, hepatocellular carcinoma, tumor size, recurrence-free survival, propensity score analysis

Dove Medical Press (Taylor and Francis Group)
Openalex Percentile: Top 6%
Hepatocellular Carcinoma Treatment and Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comparable Long-Term Survival After Curative Hepatectomy for Solitary Large (5–10 cm) versus Giant (≥10 cm) Hepatocellular Carcinoma: A Retrospective Study — Jingfei Li, Kunyuan Jiang, et al. · Dove Medical Press (Taylor and Francis Group) (2026) | TGRS Research Map | TGRS